HomeFirstView ArticlesPredictive value of immune-modified Glasgow prognostic score in patients with head and neck squamous cell carcinoma treated with nivolumab
Predictive value of immune-modified Glasgow prognostic score in patients with head and neck squamous cell carcinoma treated with nivolumab
Join Our Community
If you would like to submit events to the JLO community please register by clicking the button below.
Register